![]() |
市場調查報告書
商品編碼
1494747
到 2030 年獸醫保健市場預測:按產品、疾病、最終用戶和地區進行的全球分析Veterinary Healthcare Market Forecasts to 2030 - Global Analysis By Product, Disease, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球獸醫保健市場規模為 460.7 億美元,預計預測期內複合年成長率為 11.11%,到 2030 年將達到 866.9 億美元。
獸醫保健涵蓋頻譜的醫療服務,旨在促進動物的福祉和健康。包括針對各種動物物種(包括寵物、牲畜、野生動物和異國風動物)的預防措施、診斷、治療和復原。獸醫透過其在外科、內科、牙科、營養、行為等方面的專業知識,在保護動物福利、公共衛生和環境方面發揮重要作用。其職責不僅限於照顧個別動物,還包括疾病控制、疫苗接種計劃以及旨在推進醫學知識和改善醫療保健結果的研究。
根據美國寵物產品協會的數據,獸醫支出正在穩步成長,2021 年美國消費者在獸醫護理和產品銷售上的支出為 1,236 億美元。
寵物保險增加
隨著越來越多的人購買寵物保險,即使在非緊急情況下也越來越希望去看獸醫。這項變更減少了可能阻礙飼主為其動物接受預防性和定期治療的經濟障礙。因此,獸醫可以增加患者數量,投資先進的設備、設施和培訓,並提高整體護理品質。此外,保險範圍鼓勵飼主遵守治療計劃和後續觀察預約,從而改善寵物的健康狀況。
景氣衰退
景氣衰退可能對獸醫保健市場產生重大影響。在經濟狀況,寵物飼主可能會削減非必要開支,包括獸醫護理、選擇更便宜的替代療法或推遲定期就診。因此,對獸醫服務和產品的需求將減少,最終影響獸醫院和製藥公司的收益。然而,由於經濟不確定性,消費者推遲或放棄購買新寵物,需求可能會進一步下降。
動物醫學的進展
MRI 和電腦斷層掃描等先進影像技術等創新技術可以更準確地診斷動物的複雜疾病狀況。藥物開發提供了更有效、副作用更少的藥物,改善了動物的治療結果和生活品質。此外,微創手術技術透過減少恢復時間和術後併發症進一步推動獸醫學的發展。整合遠端醫療可以實現遠端諮詢和監控,改善獸醫服務的獲取,特別是在服務不足的地區。
獸醫短缺
提供護理的專業人員數量的減少將增加現有獸醫的負擔,增加預約的等待時間,減少獲得獸醫服務的機會,並使從業人員更加忙碌,提供護理的能力可能會下降。然而,獸醫短缺也限制了獸醫診所向服務不足地區的擴張,加劇了伴同性動物和牲畜獲得醫療保健的不平等。缺乏能夠推動研究和實施進步的專家限制了該領域創新療法和技術的開發和實施。
COVID-19 大流行對獸醫保健市場產生了重大影響。我們看到寵物飼主的行為發生了顯著變化,許多人花更多時間待在家裡,鎖上門,並且更加關注寵物的健康和福祉。寵物擁有量的迅速增加以及對寵物健康的關注導致對預防保健、疫苗接種和遠端醫療諮詢等獸醫服務的需求增加。然而,法規和安全措施暫時關閉了一些獸醫診所並減少了親自就診,影響了常規和非緊急護理。
預計過敏領域在預測期內將是最大的。
預計過敏領域在預測期內將是最大的。隨著全球寵物數量的增加,人們對寵物健康問題(包括過敏)的認知也隨之提高。這種認知導致了對專用針對寵物的過敏治療、診斷和低過敏產品的研發投資的增加。獸醫醫院正在擴大服務範圍,包括過敏測試和治療選擇,吸引了為毛茸茸的同伴尋求全面護理的飼主。此外,製藥公司正在推出針對寵物過敏的新藥和疫苗,進一步推動市場成長。
預計獸醫醫院產業在預測期內的複合年成長率最高。
獸醫醫院部門預計在預測期內將出現最高的複合年成長率,因為它為各種動物物種(包括寵物、牲畜和異國風動物)提供廣泛的專業藥品、補充品和其他保健產品。透過專注於動物用藥品,這些藥房確保獲得傳統人類藥房可能無法輕易獲得的重要藥物。此外,獸醫藥房通常僱用具有動物健康專業知識的員工,他們可以為寵物飼主和牲畜生產者提供個人化的指導和建議。
北美地區將成為整個估計期間最大的市場佔有率。獸醫醫院的區域擴張不僅改善了動物獲得優質醫療保健的機會,而且促進了獸醫醫學的創新。這些醫院注重預防性護理、早期發現和先進治療,為該地區的獸醫護理制定了標準。
透過確保動物用藥品和服務的安全性、有效性和質量,預計亞太地區將在預測期內實現有益成長。政府法規通常包括動物用藥品和保健產品的註冊、生產、分銷和銷售指南。透過執行嚴格的監管標準,政府提高了產業內的透明度和課責,並增強了全部區域消費者和相關人員的信心。
According to Stratistics MRC, the Global Veterinary Healthcare Market is accounted for $46.07 billion in 2024 and is expected to reach $86.69 billion by 2030 growing at a CAGR of 11.11% during the forecast period. Veterinary healthcare encompasses a broad spectrum of medical services aimed at promoting the well-being and health of animals. It involves preventive measures, diagnostics, treatment, and rehabilitation for various animal species, including pets, livestock, wildlife, and exotic animals. Veterinarians play a crucial role in safeguarding animal welfare, public health, and the environment through their expertise in areas such as surgery, internal medicine, dentistry, nutrition, and behavior. Their responsibilities extend beyond individual animal care to disease control, vaccination programs, and research aimed at advancing medical knowledge and improving healthcare outcomes.
According to the American Pet Products Association, veterinary care spending has been steadily rising, with U.S. consumers spent US$ 123.6 billion in 2021 on veterinarian care and product sales.
Rise in pet insurance coverage
With more individuals opting for pet insurance plans, there's an increased willingness to seek veterinary care, even for non-emergency situations. This shift reduces financial barriers that might otherwise deter pet owners from seeking preventive or routine medical attention for their animals. Consequently, veterinarians experience higher patient volumes, enabling them to invest in advanced equipment, facilities, and training, thereby elevating the overall quality of care. Moreover, insurance coverage incentivizes pet owners to adhere to treatment plans and follow-up appointments, leading to better health outcomes for their pets.
Economic downturns
Economic downturns can significantly impact the veterinary healthcare market. During tough economic times, pet owners may cut back on non-essential expenditures, including veterinary care, opting for cheaper alternatives or delaying routine visits. This leads to reduced demand for veterinary services and products, ultimately affecting the revenue streams of veterinary clinics and pharmaceutical companies. However, economic uncertainty may prompt consumers to postpone or forego adopting new pets, further dampening demand.
Advancements in veterinary medicine
Innovations such as advanced imaging technologies like MRI and CT scans enable more accurate diagnoses of complex conditions in animals. Developments in pharmaceuticals have led to the availability of more effective medications with fewer side effects, improving treatment outcomes and quality of life for animals. Moreover, minimally invasive surgical techniques have reduced recovery times and post-operative complications, further advancing veterinary care. The integration of telemedicine allows for remote consultations and monitoring, increasing accessibility to veterinary services, particularly in underserved areas.
Shortage of veterinarians
With fewer professionals available to provide care, there's an increased burden on existing veterinarians, leading to longer wait times for appointments, reduced accessibility to veterinary services, and potentially compromised quality of care due to overwhelmed practitioners. However, this shortage also limits the expansion of veterinary practices into underserved areas, exacerbating disparities in access to healthcare for both companion animals and livestock. It restricts the development and adoption of innovative treatments and technologies within the field, as there are fewer experts available to drive research and implement advancements.
The Covid-19 pandemic significantly impacted the veterinary healthcare market as there was a noticeable shift in pet owner behavior, with many people spending more time at home during lockdowns, leading to increased attention to their pets' health and well-being. This surge in pet ownership and concern for pet health translated into higher demand for veterinary services, including preventive care, vaccinations, and telemedicine consultations. However, on the flip side, restrictions and safety measures also led to temporary closures of some veterinary clinics and reduced in-person visits, affecting routine procedures and non-urgent care.
The Allergies segment is expected to be the largest during the forecast period
Allergies segment is expected to be the largest during the forecast period. As pet ownership rises globally, so does awareness of pet health issues, including allergies. This awareness has led to increased investment in research and development of allergy treatments, diagnostics, and hypoallergenic products tailored specifically for pets. Veterinary clinics are expanding their services to include allergy testing and treatment options, attracting pet owners seeking comprehensive care for their furry companions. Moreover, pharmaceutical companies are introducing new medications and vaccines targeting pet allergies, further fueling market growth.
The Veterinary Pharmacies segment is expected to have the highest CAGR during the forecast period
Veterinary Pharmacies segment is expected to have the highest CAGR during the forecast period as these pharmacies offer a wide range of medications, supplements, and other healthcare products specifically formulated for various species, including pets, livestock, and exotic animals. By focusing solely on veterinary medications, these pharmacies ensure the availability of essential drugs that may not be readily accessible in traditional human pharmacies. Moreover, veterinary pharmacies often employ staff with expertise in animal health, enabling them to offer personalized guidance and advice to pet owners and livestock producers.
North America region is poised to hold the largest market share throughout the estimated period of time as these increasing investments in veterinary hospitals are leading to the establishment of state-of-the-art facilities equipped with advanced diagnostic tools, treatment options, and specialized care services for pets. The regional expansion of veterinary hospitals is not only improving access to quality healthcare for animals but also driving innovation in veterinary medicine. With a focus on preventive care, early detection, and advanced treatments, these hospitals are raising the standard of veterinary healthcare in the region.
Asia Pacific region is estimated to gain profitable growth over the extrapolated period by ensuring the safety, efficacy, and quality of veterinary products and services. Government regulations often include guidelines for the registration, manufacturing, distribution, and marketing of veterinary medicines and healthcare products. By enforcing stringent regulatory standards, governments promote transparency and accountability within the industry, fostering trust among consumers and stakeholders across the region.
Key players in the market
Some of the key players in Veterinary Healthcare market include Zoetis Animal Healthcare, Ceva Animal Health Inc, Elanco Animal Health, Phibro Animal Health, Boehringer Ingelheim International GmbH, SeQuent Scientific Ltd, Cargill Inc, MSD Animal Health, Sanofi-Aventis, Bayer Healthcare and Novartis International AG.
In September 2022, Merck Animal Health announced the new label indication for both Bravectoand BravectoPlus for topical use in cats to treat and control Asian long-horned tick infestations. Bravectoand BravectoPlus for cats is the first and only U.S. product labeled for treatment and control.
In January 2022, Zoetis announced that the U.S. Food and Drug Administration (FDA) had approved a new label indication for SimparicaTrio (sarolaner, moxidectin, and pyrantel chewable tablets) for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks (black-legged or deer ticks). SimparicaTrio is approved for dogs eight weeks of age and older.